CAS RN: 94670-75-4
1,3-Benzodioxole, 5-bromo-6-fluoro-
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251229
100mg / 250mg / 500mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 94670-75-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
94670-75-4 / 5-bromo-6-fluoro-1,3-benzodioxole
Standard CAS: 94670-75-4
Multi CAS: No
Basic Information
copy
CAS
94670-75-4 copy
Multi CAS
No copy
Molecular Formula
BC7H4O2Rf copy
Molecular Weight
219.010000 copy
Exact Mass
217.937870 copy
InChI
InChI=1S/C7H4BrFO2/c8-4-1-6-7(2-5(4)9)11-3-10-6/h1-2H,3H2 copy
InChIKey
DDBULQVCBPPQPN-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.14 copy
H-bond acceptors
2 copy
Molar refractivity
40.22 copy
TPSA
18.46 copy
LogP / Solubility
WLOGP
2.32 copy
MLOGP
2.04 copy
XLogP3
2.5 copy
Consensus LogP
2.29 copy
Log S (ESOL)
-3.06 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.03 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.01 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.41 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy